Back
35· Cooling
Technology4h 0m ago
Researchers identified underlying molecular mechanisms of platinum resistance in triple-negative breast cancers with TP53 mutations and LIG1 gene loss, and used combinations of available drugs to reduce tumor growth in animal models.
Baylor College of Medicine
Who
researchers at Baylor College of Medicine and collaborating institutions
What
Researchers identified underlying molecular mechanisms of platinum resistance in triple-negative breast cancers with TP53 mutations and LIG1 gene loss, and used combinations of available drugs to reduce tumor growth in animal models.
When
Sat, 18 Jul 2026 00:40:01 GMT · 4h 0m ago
Where
Baylor College of Medicine ·
Why
Loss of one copy of the DNA ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy.
The Frontline Impact
How this affects you
This research identified a therapeutic vulnerability in certain triple-negative breast cancers, potentially leading to new treatment strategies and patient stratification for clinical trials.
Story chain
1 event in this threadNo related history yet - this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.